Fingerprint
Dive into the research topics of 'A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically